Results 61 to 70 of about 18,738 (216)

Clinical Validation of a Urine Test (Uromonitor-V2^®) for the Surveillance of Non-Muscle-Invasive Bladder Cancer Patients

Diagnostics, 2020
The costly and burdensome nature of the current follow-up methods in non-muscle-invasive bladder cancer (NMIBC) drives the development of new methods that may alternate with regular cystoscopy and urine cytology.
Caroline A. Sieverink, Rui P. M. Batista, Hugo J. M. Prazeres, João Vinagre, Cristina Sampaio, Ricardo R. Leão, Valdemar Máximo, J. Alfred Witjes, Paula Soares   +8 more
doaj   +1 more source

Urinary Small Extracellular Vesicle DNA as a Biomarker for the Non‐Invasive Diagnosis of Bladder Cancer

Cancer Science, EarlyView.
Clinical application scenarios for the diagnosis of BC. A schematic diagram illustrating the use of sEV DNA liquid biopsy technology to differentiate between benign and bladder cancer patients. ABSTRACT Existing diagnostic technologies for bladder cancer (BC) suffer from low sensitivity, low specificity, or a lack of validation.
Tao Wang, Xin Liao, Jiyang Zhang, Xiaoya Xu, Wei Zhang, Xinlin Chen, Xinyu Zhai, Tongtong Zhang, Xiangyang Zhan, Xingyu Mu, Dadong Zhang, Jian Chen, Dongliang Xu, Mingyue Tan   +13 more
wiley   +1 more source

When Small Cells Matter: Diagnosing Bladder Small Cell Carcinoma on Urine Cytology

Cytopathology, EarlyView.
Small cell carcinoma of the bladder is rare, aggressive and diagnostically challenging on urine cytology. We report a case detected in urine and confirmed by cell block immunohistochemistry, highlighting the importance of careful assessment and limitations of the Paris System.
Haley Corbin, Samer Khader, Gabriela Quiroga‐Garza, Liron Pantanowitz   +3 more
wiley   +1 more source

Sensitivity and specificity of 47 kDa polyclonal antibody for detection of bladder cancer cells in urine of hematuria patients

African Journal of Urology, 2018
Objective: To investigate the performance analysis of immunocytochemistry using 47 kDa polyclonal antibody compared with cytology in urine of patients hematuria symptom.
H. Prasetya, B.B. Purnomo, K. Mintaroem, S.R. Prawiro   +3 more
doaj   +1 more source

Cytological urine screening [PDF]

Journal of Clinical Pathology, 1977
R, Buchanan, M J, Sworn, J, Hawthorne, J D, Redmill   +3 more
openaire   +2 more sources

Cytopathology Terminology Systems: European Federation of Cytological Societies Survey on Practice in Europe

Cytopathology, EarlyView.
Cytology terminologies are widely accepted within Europe based on EFCS survey. The Bethesda System for reporting cervical cytology and the Bethesda System for reporting thyroid cytopathology have been implemented by most of the responding countries. ABSTRACT Cytopathologists communicate with clinicians via cytopathology reports.
Ivana Kholová, Colleen Vrbin, Esther Diana Rossi, David Poller, Pinar Firat, Sevgen Onder, Beatrix Cochand‐Priollet, Henrik Griesser, Guido Fadda, Marianne Engels, Massimo Bongiovanni, Pio Zeppa, Ashish Chandra, Ambrogio Fassina, Philippe Vielh, Danijela Vrdoljak‐Mozetic, European Federation of Cytological Societies National Representatives, Shaira Sahebali, Pawel Gajdzis, Christina Kåbjörn Gustafsson, Monique Courtade‐Saidi, Maria Nasioutziki, Filipa Moreno, Robby Kibbelaar, Jaroslava Dušková, Wolfgang Pokieser, Margareta Strojan Fležar, Maria D. Lozano, Oksana Sulaieva, Pavlina Botsiun, Laszlo Vass, Ljube Ivkovski, Tibor Mezei, Nina Juric, Mikk Abram, Cornelia Amalinei, Milana Panjkovic, Dalius Baltusnikas, Aleksandrina Vlahova, Rene Gerhard, Cioly Rivero‐Colmenarez, Ljiljana Vučković, Fatlinda Sadiku, Giovanni Negri, Erion Sukaj, Jurate Asmundsson, Lucia Krivošíková   +46 more
wiley   +1 more source

Five Advances in the Last 50 Years That Have Impacted Endocrine Surgery

World Journal of Surgery, EarlyView.
Matilda Anneback, Priya H. Dedhia, Aimee Di Marco, Els Nieveen van Dijkum, Julie A. Miller, Janice L. Pasieka   +5 more
wiley   +1 more source

From Tumour to Bloodstream: Advancing PD‐L1 Testing With Liquid Biopsies in Non‐Small Cell Lung Cancer

Cytopathology, EarlyView.
This review explores liquid biopsy as a complementary approach to tissue‐based PD‐L1 assessment in advanced NSCLC treated with immune checkpoint inhibitors. Focusing on circulating tumour cells, extracellular vesicles, and circulating tumour DNA, it summarises current evidence, technical challenges, and future perspectives for personalised ...
R. Leporati, V. Callegari, A. Ancora, M. Palmieri, B. Riccò, E. Cabitza, L. Trudu, K. Di Emidio, C. Chiavelli, A. Eccher, I. Mastrolia, V. Catani, S. Bettelli, G. Guaitoli, M. Dominici, F. Bertolini   +15 more
wiley   +1 more source

COVID‐19's Shadow: The Effect of COVID‐19 on Cytopathology Specimens Received at an Academic Laboratory in Central South Africa

Cytopathology, EarlyView.
Due to global COVID‐19‐related disruptions in healthcare delivery, cytopathology laboratories experienced a reduction in specimen volume that did not fully recover post‐COVID‐19. The findings of the study highlighted the importance of resilient diagnostic services during health crises.
Courtney T. A. Bonato, Greta Neethling, Liska Budding   +2 more
wiley   +1 more source

Sarcoma in urine cytology; an extremely rare entity: A report of two cases

Journal of Cytology, 2017
Primary sarcomas of the urinary bladder or prostate are extremely rare entities. The rarity and lack of awareness makes it difficult for the cytologists to detect the spindle cell lesions in urine for malignant cytology.
Suvradeep Mitra, Gurwinder Kaur, Nandita Kakkar, Priya Singh, Pranab Dey   +4 more
doaj   +1 more source